Combined inhibitory effects of curcumin and 5-fluorouracil on growth of human colon carcinoma cell line HT-29

Chinese Journal of Pharmacology and Toxicology

Volumn 19, Issue 1, 2005, Pages 49-52

  Du, Bo Yu ^a   Jiang, Li Ping ^a   Zhong, Lai Fu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Colonic neoplasms; Curcumin; HT 29 cells; Synergistic effect

Indexed keywords

CURCUMIN; FLUOROURACIL;

ANALYTICAL ERROR; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL GROWTH; CELL STRAIN HT29; COLON CARCINOMA; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 14744295317     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells [J]. Cancer Lett, 2001, 172(2):111-118.
2. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho W, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions[J]. Anticancer Res, 2001, 21(4B):2895-2900.
3. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, et al. Strategy and planning for chemopreventive drug development: clinical development plans II [J]. J Cell Biochem Suppl, 1996, 26:54-71.
4. Li WD, Zhang ML, PU YF. Study on inhibiting effect of ATRA and cisplatin on human hepatoma cell[J]. Chin J Public Health, 2004, 20(4):459-460.
5. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors[J]. Adv Enzyme Regul, 1984, 22:27-55.
6. Chou TC, Motzer RJ, Tong Y, Bosl GJ. Computerized quantitation of synergism and antagonism of Taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design[J]. J Natl Cancer Inst, 1994, 86(20): 1517-1524.
7. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice [J]. Cancer Res, 1994, 54(22):5841-5847.
8. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound[J]. Cancer Res, 1995, 55(2):259-266.
9. Labianca R, Pessi A, Facendola G, Pirovano M, Luporini G. Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studies [J]. Eur J Cancer, 1996, 32A(Suppl 5):S7-S12.
10. Chuang SE, Yeh PY, Lu YS, Lai GM, Liao CM, Gao M, et al. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells[J]. Biochem Pharmacol, 2002, 63(9): 1709-1716.